Details for New Drug Application (NDA): 203269
✉ Email this page to a colleague
The generic ingredient in RIZATRIPTAN BENZOATE is rizatriptan benzoate. There are twenty-two drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the rizatriptan benzoate profile page.
Summary for 203269
| Tradename: | RIZATRIPTAN BENZOATE |
| Applicant: | Alkem Labs Ltd |
| Ingredient: | rizatriptan benzoate |
| Patents: | 0 |
Pharmacology for NDA: 203269
| Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Suppliers and Packaging for NDA: 203269
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET;ORAL | 203269 | ANDA | A-S Medication Solutions | 50090-3343 | 50090-3343-0 | 3 BLISTER PACK in 1 CARTON (50090-3343-0) / 6 TABLET in 1 BLISTER PACK |
| RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET;ORAL | 203269 | ANDA | Ascend Laboratories, LLC | 67877-261 | 67877-261-01 | 100 TABLET in 1 BOTTLE (67877-261-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE | ||||
| Approval Date: | Feb 18, 2016 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
| Approval Date: | Feb 18, 2016 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
